Whitehawk Therapeutics, Inc.
Public company- Headquarters
- MORRISTOWN, New Jersey
- Ticker
- WHWK
- CIK
- 0001422142
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Sep 10, 2026
Executive appointmentClass III director appointed: Vijay Iyengar, M.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class III directorVijay Iyengar, M.D. | Sep 10, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- ELITE PHARMACEUTICALS INC /NV/
Class I director appointed: John W. LaRocca, Esq.
- Executive appointment
Class III director appointed: Vijay Iyengar, M.D.
Vijay Iyengar, M.D. was named Class III director of Whitehawk Therapeutics, Inc., effective September 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 10, 2026Role: Class III director
Only one public record so far. We add events as soon as a new filing lands; watch Whitehawk Therapeutics, Inc. to get them in your digest.
Last verified Nov 8, 2026